Intelence and Kisqali (600 MG Dose)
Determining the interaction of Intelence and Kisqali (600 MG Dose) and the possibility of their joint administration.
In the database of official manuals used in the service creation an interaction registered by statistical results of studies was found, which can either lead to negative consequences for the patient health or strengthen a mutual positive effect. A doctor should be consulted to address the issue of joint drug administration.
Consumer:Using ribociclib together with etravirine can alter the blood levels and effects of both medications. Specifically, ribociclib blood levels may decrease, which may make the medication less effective. At the same time, etravirine blood levels may increase. Contact your doctor if your condition changes or you experience increased side effects. You may need a dose adjustment or more frequent monitoring by your doctor to safely use both medications. It is important to tell your doctor about all other medications you use, including vitamins and herbs. Do not stop using any medications without first talking to your doctor.
Professional:MONITOR: Coadministration of etravirine with a drug that is both a substrate as well as inhibitor of CYP450 3A4 may result in increased plasma concentrations of etravirine and decreased plasma concentrations of the other drug. Etravirine itself is a substrate and inducer of CYP450 3A4. Theoretically, etravirine may induce metabolism of the coadministered drug while its own metabolism may be inhibited by the coadministered drug.
MANAGEMENT: Because safety data regarding increased etravirine exposures are limited, caution is advised if etravirine is prescribed in combination with a drug that is an inhibitor of CYP450 3A4. In addition, dosage adjustments may be required for the coadministered drug if it is also a substrate of CYP450 3A4.
- "Product Information. Intelence (etravirine)." Ortho Biotech Inc, Bridgewater, NJ.
Generic Name: ribociclib
Brand name: Kisqali
Synonyms: Kisqali
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Intelence-Kisqali Femara Co-Pack
- Intelence-Kisqali Femara Co-Pack 200 mg-2.5 mg Dose
- Intelence-Kisqali Femara Co-Pack 400 mg-2.5 mg Dose
- Intelence-Kisqali Femara Co-Pack 600 mg-2.5 mg Dose
- Intelence-Kitabis Pak
- Intelence-Kitabis Pak inhalation
- Kisqali (600 MG Dose)-Interferon alfa-2b
- Kisqali (600 MG Dose)-Interferon alfa-2b Injection
- Kisqali (600 MG Dose)-Interferon Alfa-2b Injection Solution
- Kisqali (600 MG Dose)-Interferon Alfa-2b Powder for Injection
- Kisqali (600 MG Dose)-Interferon Alfa-2b Prefilled Pens
- Kisqali (600 MG Dose)-Interferon alfa-n3